Both in Pharmaceuticals
Indaptus Therapeutics vs Prothena
Over the past year INDP returned +4.8% and PRTA returned −20.1%; their daily moves had a correlation of 0.15.
INDP +4.8% PRTA −20.1%Growth of $1, one year, split-adjusted
| Metric | INDP | PRTA |
|---|---|---|
| Price | $3.24 | $8.21 |
| Market cap | $431.7M | $421.5M |
| Today | −7.43% | −0.96% |
| 1 month | +29.1% | −0.7% |
| 6 months | +55.0% | −26.6% |
| Year to date | +11.3% | −14.0% |
| 1 year | +0.6% | −23.6% |
| Revenue growth (YoY) | — | −77.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −1839.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.7× |
| Net cash | $11.6M | $288.2M |
| Dividend yield | — | — |
| Volatility (60d) | 193.5% | 45.7% |
| Short % of float | 7.4% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).